Education
About Us
Working with TipRanks
Follow Us
Fulgent Genetics (FLGT)
:FLGT
Total Valuation
Fulgent Genetics has a market cap or net worth of $806.85M. The enterprise value is ―.
Market Cap$806.85M
Enterprise Value―
Share Statistics
Fulgent Genetics has 30,609,043 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30,609,043
Owned by Insiders35.50%
Owned by Institutions<0.01%
Financial Efficiency
Fulgent Genetics’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -5.42%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)-5.42%
Return on Capital Employed (ROCE)-0.06
Revenue Per Employee215.89K
Profits Per Employee-33.37K
Employee Count1,313
Asset Turnover0.23
Inventory Turnover21.02
Valuation Ratios
The current PE Ratio of Fulgent Genetics is ―. Fulgent Genetics’s PEG ratio is 0.17.
PE Ratio―
PS Ratio1.97
PB Ratio0.49
Price to Fair Value0.49
Price to FCF-29.00
Price to Operating Cash Flow548.35
PEG Ratio0.17
Income Statement
In the last 12 months, Fulgent Genetics had revenue of 283.47M and earned -42.71M in profits. Earnings per share was -1.41.
Revenue283.47M
Gross Profit107.22M
Operating Income-73.92M
Pretax Income-51.96M
Net Income-42.71M
EBITDA-48.99M
Earnings Per Share (EPS)-1.41
Cash Flow
In the last 12 months, operating cash flow was 1.52M and capital expenditures -21.37M, giving a free cash flow of -19.85M billion.
Operating Cash Flow1.52M
Free Cash Flow-19.85M
Free Cash Flow per Share-0.65
Dividends & Yields
Fulgent Genetics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.34
52-Week Price Change41.75%
50-Day Moving Average22.90
200-Day Moving Average19.83
Relative Strength Index (RSI)78.38
Average Volume (3m)225.71K
Important Dates
Fulgent Genetics upcoming earnings date is Feb 26, 2026, After Close (Confirmed).
Last Earnings DateNov 7, 2025
Next Earnings DateFeb 26, 2026
Ex-Dividend Date―
Financial Position
Fulgent Genetics as a current ratio of 4.85, with Debt / Equity ratio of 0.04%
Current Ratio4.85
Quick Ratio4.74
Debt to Market Cap<0.01
Net Debt to EBITDA0.94
Interest Coverage Ratio-434.81
Taxes
In the past 12 months, Fulgent Genetics has paid -8.14M in taxes.
Income Tax-8.14M
Effective Tax Rate0.16
Enterprise Valuation
Fulgent Genetics EV to EBITDA ratio is -10.46, with an EV/FCF ratio of -26.62.
EV to Sales1.81
EV to EBITDA-10.46
EV to Free Cash Flow-26.62
EV to Operating Cash Flow24.34
Balance Sheet
Fulgent Genetics has $375.80M in cash and marketable securities with $7.99M in debt, giving a net cash position of $367.81M billion.
Cash & Marketable Securities$375.80M
Total Debt$7.99M
Net Cash$367.81M
Net Cash Per Share$12.02
Tangible Book Value Per Share$32.15
Margins
Gross margin is 41.24%, with operating margin of -26.08%, and net profit margin of -15.07%.
Gross Margin41.24%
Operating Margin-26.08%
Pretax Margin-18.33%
Net Profit Margin-15.07%
EBITDA Margin-17.28%
EBIT Margin-26.08%
Analyst Forecast
The average price target for Fulgent Genetics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast13.60%
EPS Growth Forecast74.64%